Question Bank › Quarter got stronger as it went

Quarter got stronger as it went

Quarter got stronger as it went: management narrates intra-period acceleration with company-specific drivers still in fo

Calls Tested
486
Answered YES
8
Hit Rate
1.6%
rare by design

OPKO Health, Inc. (OPK) — this company's answers

NO on the Q1 2022 call 2022-05-09 D
The model's full reasoning — Q1 2022 call → NO我们根据提供的财报电话会议记录来判断。问题核心:管理层是否传达报告期结束时比开始时更强,并且这种增强主要归因于公司自身且仍在持续的驱动因素。 分析记录内容: - 关于诊断部门(BioReference):Jon Cohen提到“As COVID testing has waned, BioReference continues to focus on its strategy to grow its core diagnostic business”,并提到“Volume in our clinical base business increased 4% versus the fourth quarter”,但这是与上季度比较,不是期内趋势。他提到COVID测试量在2月和3月下降(“As expected, our COVID volume trended down in February and March after the Omicron surge in December and January”),所以COVID测试是下降的。核心业务有增长,但未明确说期内从弱到强。 - 关于ModeX收购,这是新宣布的,不是报告期内的业务进展。 - 关于财务:Adam Logal提到“margins during the first quarter were impacted by an increase in labor costs while we manage through the surge in testing coming from the Omnicron variant as well as a significant portion of our test volume coming from our point-of-care testing channels”,并说“Once the Omnicron surge subsided, we took aggressive actions to rightsize our workforce and began to realize those actions -- our gross margin exit rates were in line with our full-year expectations.” 这里提到“exit rates”可能暗示期末有所改善,但并未明确说业务活动增强,而是说成本调整后利润率恢复。 - 关于COVID测试量:第一季度做了2百万测试,第四季度2.7百万,下降。没有提到期内逐月上升。 - 关于核心业务:Jon Cohen提到“Volume in our clinical base business increased 4% versus the fourth quarter”,但这是环比,不是期内趋势。他提到“Our noninvasive prenatal testing business grew substantially up almost 16,000 samples year-over-year or a 219% increase.” 这是同比,不是期内。 - 没有明确描述“period ended stronger than it began”的叙述。管理层没有说“我们开始缓慢,但后来加速”之类的话。他们提到COVID下降,核心业务增长,但未描述期内从弱到强的过程。 - 关于驱动因素:如果提到增长,主要归因于商业保险地位(Aetna, UnitedHealthcare)和Scarlet Health等,但这些是持续存在的,但未明确说期内加速。 - 整体上,管理层没有明确说报告期结束时比开始时更强。他们提到COVID测试量下降,核心业务有增长,但未描述期内动态。因此,答案应为NO。 注意:问题要求“using ONLY the supplied earnings call transcript”,我们只基于此。没有明确证据表明期内从弱到强。所以回答NO。

← Back to the full OPK analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that the just-reported period STRENGTHENED AS IT PROGRESSED — that business conditions, activity, or execution were meaningfully better in the later part of the period (or in the weeks right after it) than in the earlier part — AND does management attribute that building strength mainly to drivers attached to the company itself that are described as still in force now? Answer YES when management's own words convey, in whatever form fits the business, BOTH halves of ONE coherent story: (1) THE PERIOD ENDED STRONGER THAN IT BEGAN. Management describes the reported stretch not as uniformly good or bad but as visibly improving through its course — for example: orders, sales, volumes, traffic, bookings, utilization, output, sign-ups, or activity picking up month over month or as the period went on; a slow start followed by a strong finish; momentum, win rates, or customer activity building toward the end of the period; the current or exit pace of business running above the period's average; or the early weeks of the new period continuing at the stronger late-period pace. The improvement must be described as something already observed in real activity — grounded in what actually happened during or just after the period — not merely a forecast, a hope, or a raised outlook. (2) THE CAUSE IS COMPANY-ATTACHED AND STILL WORKING. When management explains why things strengthened, the explanation rests chiefly on something belonging to the company — a product or offering gaining traction, customers adopting or expanding, a capability, capacity, location, fix, launch, or change the company put in place now taking hold, business recently won now converting, or execution improvements now showing through — and management conveys, directly or plainly in substance, that these drivers remain in effect and have more to give in the coming periods, so the late-period strength is presented as the beginning of a trajectory rather than a bulge that is now over. Answer NO if management describes the period as uniformly strong, uniformly weak, flat, or mixed, with no clear internal progression from weaker to stronger. NO if the late-period pickup is attributed mainly to normal seasonality, a holiday or weather pattern, an easy comparison, a one-time order or event, catch-up shipments, pull-forward ahead of a price change or deadline, or anything management itself expects to unwind or normalize. NO if the strengthening is credited chiefly to outside forces — the market, industry demand, commodity prices, macro conditions, or a competitor's stumble — rather than to something of the company's own. NO if the improvement is only projected or guided rather than already observed in the period's actual progression. NO if management describes momentum flattening, slowing, or normalizing as the period ended. NO if the intra-period acceleration appears only in an analyst's question or model that management does not itself confirm in its own account of the business. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
ASM Avino Silver & Gold Mines Ltd. Q4 2023 2024-03-21 C+
CMG Chipotle Mexican Grill, Inc. Q3 2023 2023-10-27 B+
CHUY Chuy's Holdings, Inc. Q3 2022 2022-11-05 C+
CHE Chemed Corporation Q3 2022 2022-11-01 B+
TMCI Treace Medical Concepts, Inc. Q2 2022 2022-08-13 B+
OGI OrganiGram Holdings Inc. Q3 2022 2022-07-14 B+
CCRN Cross Country Healthcare, Inc. Q1 2022 2022-05-04 B
KHC The Kraft Heinz Company Q1 2017 2017-05-03 F

How the model reasoned

KHC · Q1 2017 → YESThe question is: Does management convey that the just-reported period STRENGTHENED AS IT PROGRESSED — that business conditions, activity, or execution were meaningfully better in the later part of the...YES The transcript shows management describing a clear intra-period progression: a slow start in January and February followed by "marked improvement as the quarter progressed," with "more favorable consumption trends in both March and April" and "early read of Easter trading." They explicitly tie this to company-driven factors that remain active, including Big 2017 bets (Devour frozen meals, Cracker Barrel Mac & Cheese, Lunchables, Oscar Mayer renovation, Philadelphia Cheesecake Cups, etc.) already in-market and driving double-digit gains, plus upcoming scale events and innovation pipeline that will continue to support growth through the second half.
CCRN · Q1 2022 → YESThe question is: Does management convey that the just-reported period STRENGTHENED AS IT PROGRESSED — that business conditions, activity, or execution were meaningfully better in the later part of the...YES The transcript shows clear intra-period strengthening: William Burns explicitly states the company “grew sequentially throughout the quarter” with “travel… on assignment, continued to grow each and every month of the quarter,” exiting higher than it entered. This is presented as already-observed activity, not a forecast.
CHUY · Q3 2022 → YESThe question is: Does management convey that the just-reported period STRENGTHENED AS IT PROGRESSED, and attribute that building strength mainly to company-attached drivers that are still in force? YES The transcript shows management describing the quarter as starting slow in July but finishing with strong momentum in August and September (with continued improvement into Q4), and attributes this primarily to company-driven factors like staffing improvements and social media upticks that were already in place and noted as still active.

More from the question bank

Volume already booked into a capability thatBetting the balance sheet on one live opportCall runs ahead of the accountsScheduled future in administrationEcosystem forming: independent outsiders areMomentum handoff to a young engineAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.